Picture of ATTANA AB logo

ATANA ATTANA AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+5.32%
3m-27.77%
6m-74.3%
1yr-66.29%
Volume Change (%)
10d/3m-34.71%
Price vs... (%)
52w High-81.05%
50d MA-13.26%
200d MA-57.82%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-60.26%
Return on Equity-79.72%
Operating Margin-245.59%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of ATTANA AB EPS forecast chart

Profile Summary

Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    May 10th, 2013
    Public Since
    March 7th, 2018
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    se flag iconNordic Growth Market - Stockholm
    Shares in Issue
    272,657,759

    ATANA Share Price Performance

    Similar to ATANA

    Picture of Coegin Pharma AB logo

    Coegin Pharma AB

    se flag iconNordic Growth Market - Stockholm

    Picture of Lumito AB (publ) logo

    Lumito AB (publ)

    se flag iconNordic Growth Market - Stockholm

    Picture of Lumito AB (publ) logo

    Lumito AB (publ)

    se flag iconNordic Growth Market - Stockholm

    Picture of Prolight Diagnostics AB (publ) logo

    Prolight Diagnostics AB (publ)

    se flag iconNordic Growth Market - Stockholm

    FAQ